Cosmetic Manufacturers Preparing For MoCRA Safety Substantiation Should Look To EU – Attorneys
Executive Summary
Manufacturers looking for a model of safety substantiation in order to comply with the US Modernization of Cosmetics Regulation Act of 2022 should consider the framework required by the EU’s Cosmetic Products Regulation, says Steptoe & Johnson associate Surya Kundu. Attorneys also discussed new requirements for adverse event reporting during a FDLI webinar on MoCRA.
You may also be interested in...
MoCRA Check-In: Abundance Of New Requirements, Enforcement Remains To Be Seen
EAS Consulting Group’s John Bailey continues to chronicle regulatory developments under the Modernization of Cosmetic Regulations Act. In this installment, he outlines industry stakeholders’ questions and concerns related to 2023 announcements from the US FDA and provisions of the law that became effective (if not yet enforced) at year-end.
MoCRA Consultancy To Exempt Small Businesses: Tackle Product Listing While Stakes Are Low
Small businesses not required to register products with the FDA under new cosmetics regulations should consider doing so anyway in order to stay ahead of evolving requirements and complete work while ‘stakes are lower,’ said cosmetics software and consulting firm Good Face Project in a recent MoCRA webinar.
Canada’s Cosmetic Animal-Testing Ban: What It Means For China Testing, New Ingredients, USA
Canada’s prohibitions on cosmetic animal testing enter into force in December, largely in line with EU, California and other bans around the globe, but with some notable distinctions. “Now it's really time to increase the pressure in the US – action can't be far behind,” says Brandi Halls, chief ethics officer at Lush Cosmetics, North America.